1. Rock C, Wong BC, Dionne K, et al. Pseudo-outbreak of Sphingomonas and Methylobacterium sp. Associated with Contamination of Heparin-Saline Solution Syringes Used During Bone Marrow Aspiration. Infection control and hospital epidemiology 2016;37:116-7. 2. Lai H, Moore R, Celentano DD, et al. HIV Infection Itself May Not Be Associated With Subclinical Coronary Artery Disease Among African Americans Without Cardiovascular Symptoms. Journal of the American Heart Association 2016;4:e002529. 3. Kakouros N, Nazarian SM, Stadler PB, Kickler TS, Rade JJ. Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery. Journal of the American Heart Association 2016;4:e002615. 4. Streiff MB, Ye X, Kickler TS, et al. A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors. Journal of neuro- oncology 2015;124:299-305. 5. Lai H, Stitzer M, Treisman G, et al. Cocaine Abstinence and Reduced Use Associated With Lowered Marker of Endothelial Dysfunction in African Americans: A Preliminary Study. Journal of addiction medicine 2015;9:331-9. 6. Gavriilaki E, Yuan X, Ye Z, et al. Modified Ham test for atypical hemolytic uremic syndrome. Blood 2015;125:3637-46. 7. Huang X, Shah S, Wang J, et al. Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors. Molecular therapy : the journal of the American Society of Gene Therapy 2014;22:451-63. 8. Abt NB, Streiff MB, Gocke CB, Kickler TS, Lanzkron SM. Idiopathic Acquired Hemophilia A with Undetectable Factor VIII Inhibitor. Case reports in hematology 2014;2014:484563. 9. Takemoto CM, Streiff MB, Shermock KM, et al. Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance. American journal of clinical pathology 2013;139:450-6. 10. Kakouros N, Kickler TS, Laws KM, Rade JJ. Hematocrit alters VerifyNow P2Y12 assay results independently of intrinsic platelet reactivity and clopidogrel responsiveness. Journal of thrombosis and haemostasis : JTH 2013;11:1814-22. 11. DeFilippis AP, Oloyede OS, Andrikopoulou E, et al. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. Circulation journal : official journal of the Japanese Circulation Society 2013;77:2786-92. 12. Bembea MM, Schwartz JM, Shah N, et al. Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation. ASAIO journal 2013;59:63-8. 13. Tai H, Lai H, Jani J, Lai S, Kickler TS. HIV infection and cocaine use induce endothelial damage and dysfunction in African Americans. International journal of cardiology 2012;161:83-7. 14. Olson MT, Kickler TS, Lawson JA, et al. Effect of assay specificity on the association of urine 11- dehydro thromboxane B2 determination with cardiovascular risk. Journal of thrombosis and haemostasis : JTH 2012;10:2462-9. 15. Lai H, Gerstenblith G, Fishman EK, et al. Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54:1747-55. 16. Slichter SJ, Bolgiano D, Kao KJ, et al. Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products. Transfusion medicine reviews 2011;25:102-10. 17. Lynch DR, Jr., Kickler TS, Rade JJ. Recurrent myocardial infarction associated with gefitinib therapy. Journal of thrombosis and thrombolysis 2011;32:120-4. 18. Gluckman TJ, McLean RC, Schulman SP, et al. Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery. Journal of the American College of Cardiology 2011;57:1069-77. 19. Nazarian SM, Thompson JB, Gluckman TJ, et al. Clinical and laboratory factors associated with shear-dependent platelet hyper-reactivity in patients on chronic aspirin therapy. Thrombosis research 2010;126:379-83. 20. Mehta BM, Kiani AN, Chen C, Jani J, Kickler TS, Petri M. Endogenous thrombin potential in the assessment of hypercoagulability in systemic lupus erythematosus. American journal of hematology 2010;85:83-5. 21. Walker TJ, Nelson LD, Dunphy BW, Anderson DM, Kickler TS. Comparative evaluation of the Iris iQ200 body fluid module with manual hemacytometer count. American journal of clinical pathology 2009;131:333-8. 22. Strouse JJ, Tamma P, Kickler TS, Takemoto CM. D-dimer for the diagnosis of venous thromboembolism in children. American journal of hematology 2009;84:62-3. 23. Kickler TS. Dr William W. Duke: pioneer in platelet research. Jama 2009;301:2267-9. 24. Gluckman TJ, Segal JB, Schulman SP, et al. Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery. Journal of thrombosis and haemostasis : JTH 2009;7:1457-64. 25. Garibaldi B, Malani R, Yeh HC, et al. Estimating platelet production in patients with HIV-related thrombocytopenia using the immature platelet fraction. American journal of hematology 2009;84:852-4. 26. Asmis LM, Segal JB, Plantinga LC, et al. Heparin-induced antibodies and cardiovascular risk in patients on dialysis. Thrombosis and haemostasis 2008;100:498-504. 27. Savage WJ, Kickler TS, Takemoto CM. Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure. Pediatric blood & cancer 2007;49:1025-9. 28. Hamilton RG, Kickler TS. Bovine hemoglobin (glutamer-250, Hemopure)-specific immunoglobulin G antibody cross-reacts with human hemoglobin but does not lyse red blood cells in vitro. Transfusion 2007;47:723-8. 29. Ganesh SK, Sharma Y, Dayhoff J, et al. Detection of venous thromboembolism by proteomic serum biomarkers. PloS one 2007;2:e544. 30. Williams MS, Kickler TS, Vaidya D, Ng'alla LS, Bush DE. Evaluation of platelet function in aspirin treated patients with CAD. Journal of thrombosis and thrombolysis 2006;21:241-7. 31. Kickler TS, Oguni S, Borowitz MJ. A clinical evaluation of high fluorescent platelet fraction percentage in thrombocytopenia. American journal of clinical pathology 2006;125:282-7. 32. Danowski A, Kickler TS, Petri M. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. The Journal of rheumatology 2006;33:1775-9. 33. Brotman DJ, Girod JP, Posch A, et al. Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Thrombosis research 2006;118:247-52. 34. Williams MS, Vaidya D, Kickler T, Ouyang P. Long-term hormone replacement therapy does not cause increased platelet activation. American heart journal 2005;150:434-8. 35. Slichter SJ, Davis K, Enright H, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005;105:4106-14. 36. Kickler T. From an early National Blood Foundation award to our ongoing studies in fetal and neonatal alloimmune thrombocytopenia. Transfusion 2005;45:64S-6S. 37. Gluckman TJ, Segal JB, Fredde NL, et al. Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularization. The American journal of cardiology 2005;95:744-7. 38. Althaus J, Weir EG, Askin F, Kickler TS, Blakemore K. Chronic villitis in untreated neonatal alloimmune thrombocytopenia: an etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy. American journal of obstetrics and gynecology 2005;193:1100-4. 39. Streiff MB, Segal J, Grossman SA, Kickler TS, Weir EG. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas. Cancer 2004;100:1717-23. 40. Kickler TS, Borowitz MJ, Thompson RE, Charintranont N, Law R. Ret-Y a measure of reticulocyte size: a sensitive indicator of iron deficiency anemia. Clinical and laboratory haematology 2004;26:423-7. 41. Kickler T. Fetal and neonatal alloimmune thrombocytopenia. Clinical advances in hematology & oncology : H&O 2004;2:643-4. 42. Grover DS, Atta MG, Eustace JA, Kickler TS, Fine DM. Lack of clinical utility of urine myoglobin detection by microconcentrator ultrafiltration in the diagnosis of rhabdomyolysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19:2634-8. 43. Ziai WC, Torbey MT, Kickler TS, Oh S, Bhardwaj A, Wityk RJ. Platelet count and function in spontaneous intracerebral hemorrhage. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2003;12:201-6. 44. Sacher RA, Kickler TS, Schiffer CA, et al. Management of patients refractory to platelet transfusion. Archives of pathology & laboratory medicine 2003;127:409-14. 45. Kickler TS. Why "bloodless medicine" and how should we do it? Transfusion 2003;43:550-1. 46. Campbell-Lee SA, DeSantis-Parsons D, Shirey RS, Kickler TS. Neonatal alloimmune thrombocytopenia due to anti-HPA-5b (Bra). Immunohematology / American Red Cross 2003;19:127-31. 47. Brotman DJ, Segal JB, Jani JT, Petty BG, Kickler TS. Limitations of D-dimer testing in unselected inpatients with suspected venous thromboembolism. The American journal of medicine 2003;114:276-